Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Michael E Nakai"'
Autor:
Michael E. Nakai, Joshua Denham, Priscilla R. Prestes, Nina Eikelis, Elisabeth A. Lambert, Nora E. Straznicky, Markus P. Schlaich, Murray D. Esler, Brendan J. O’Brien, Fadi J. Charchar, Gavin W. Lambert, Francine Z. Marques
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Amongst other immune cells, neutrophils play a key role in systemic inflammation leading to cardiovascular disease and can release inflammatory factors, including lipocalin-2 (LCN2). LCN2 drives cardiac hypertrophy and plays a role in malada
Externí odkaz:
https://doaj.org/article/371176a9aded4690970dc81a03253a7d
Autor:
Anna L. Beale, Joanne A. O’Donnell, Michael E. Nakai, Shane Nanayakkara, Donna Vizi, Kaye Carter, Eliza Dean, Rosilene V. Ribeiro, Stephanie Yiallourou, Melinda J. Carrington, Francine Z. Marques, David M. Kaye
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background Risk factors for heart failure with preserved ejection fraction (HFpEF) include hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota independently contributes to each one of these risk factors, potentiall
Externí odkaz:
https://doaj.org/article/a1ad61fcc5e54dccbfc34ffeffa1aeda
Autor:
Rikeish R. Muralitharan, Michael E. Nakai, Matthew Snelson, Tenghao Zheng, Evany Dinakis, Liang Xie, Hamdi Jama, Madeleine Paterson, Waled Shihata, Flavia Wassef, Antony Vinh, Grant R Drummond, David M. Kaye, Charles R. Mackay, Francine Z. Marques
IntroductionGut microbiome studies often overlook experimental factors that could influence gut microbiome diversity and could impact findings. Large-scale studies investigating these experimental factors are lacking. Thus, we aimed to determine whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1bd1beec59c13f4bfc40c3bb817db33
https://doi.org/10.1101/2023.04.08.536089
https://doi.org/10.1101/2023.04.08.536089
Autor:
Rosilene V Ribeiro, Melinda Carrington, Rikeish R. Muralitharan, Michael E Nakai, Stephanie Yiallourou, Paul A. Gill, Francine Z. Marques, David M. Kaye, Geoffrey A. Head, Bruce R. Stevens, Jane G. Muir
Publikováno v:
Hypertension. 78:804-815
Recent evidence supports a role for the gut microbiota in hypertension, but whether ambulatory blood pressure is associated with gut microbiota and their metabolites remains unclear. We characterized the function of the gut microbiota, their metaboli
Autor:
Nora E. Straznicky, Nina Eikelis, Michael E Nakai, Francine Z. Marques, Elisabeth Lambert, Priscilla R. Prestes, Markus P. Schlaich, Gavin W. Lambert, Fadi J. Charchar, Murray D. Esler, Brendan J. O’Brien, Joshua Denham
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Amongst other immune cells, neutrophils play a key role in systemic inflammation leading to cardiovascular disease and can release inflammatory factors, including lipocalin-2 (LCN2). LCN2 drives cardiac hypertrophy and plays a role in maladaptive rem
Autor:
Hamdi A. Jama, Alexander R Pinto, Harikrishnan Kaipananickal, Francine Z Marques, Charles R. Mackay, Gabriella E. Farrugia, Ekaterina Salimova, Waled A. Shihata, Kate L. Weeks, Madeleine Paterson, Malathi I Dona, David M. Kaye, Michael E Nakai, Jun Okabe, Evany Dinakis, Assam El-Osta
Publikováno v:
Hypertension. 78
Dietary fibre is fermented by the gut microbiota and protects against the development of cardiovascular disease (CVD) through the production of gut microbial metabolites. We hypothesised dietary fibre intake during pregnancy may prevent the developme
Autor:
Madeleine Paterson, Evany Dinakis, Liang Xie, Ekaterina Salimova, Charles R. Mackay, Francine Z Marques, Caroline Ang, Hamdi A. Jama, Rikeish R. Muralitharan, Michael E Nakai, Alex Cheng Guan Peh, Remy Robert
Publikováno v:
Hypertension. 78
High fibre (HF) diet protects against hypertension via the production of acidic metabolites, e.g. short-chain fatty acids, by the gut microbiota. While these metabolites have a direct role in blood pressure (BP) regulation, their acidic nature may ac
Autor:
Joanne O'Donnell, Christopher K. Barlow, Charles R. Mackay, Maria Kaparakis-Liaskos, Rikeish R. Muralitharan, Michael E Nakai, Evany Dinakis, Chudan Xu, Madeleine Paterson, Ekaterina Salimova, Natalie J. Bitto, Francine Z Marques, Darren Creek, Hamdi A. Jama, Liang Xie
Publikováno v:
Hypertension. 78
High dietary fibre is fermented by the gut microbiota, resulting in the release of metabolites called short-chain fatty acids (SCFAs). Both fibre and SCFAs can reduce high blood pressure (BP) and its associated cardio-renal complications. However, th
The conundrum of the gut microbiome and blood pressure: the importance of studying sex and ethnicity
Publikováno v:
European Heart Journal. 41:4268-4270
Autor:
Stephanie Yiallourou, Jane G. Muir, David M. Kaye, Melinda Carrington, Paul A. Gill, Geoffrey A. Head, Yusuke Sata, Francine Z. Marques, Evany Dinakis, Michael E Nakai
Publikováno v:
Heart, lungcirculation. 30(11)
Aim Gut microbiota-derived metabolites, such as short-chain fatty acids (SCFAs) have vasodilator properties in animal and human ex vivo arteries. However, the role of the gut microbiota and SCFAs in arterial stiffness in humans is still unclear. Here